Motor Function

Pose estimation may be a quick, accurate alternative for measuring full-body movements during neurological examinations, according to a pilot study published in PLOS One.

Patients with stroke may benefit from more intensive motor rehabilitation at 60 to 90 days after stroke onset, according to results of a phase 2 clinical trial published in Proceedings of the National Academy of Sciences.

Viltepso, an injection treatment for Duchenne muscular dystrophy in patients with a confirmed mutation, demonstrated a statistically significant benefit for motor function in open-label extension results from a phase 2 study.

Evrysdi, a survival motor neuron 2-directed RNA splicing modifier, both sustained and improved motor function at 24 months in children and adults with type 2 or type 3 spinal muscular atrophy, according to results from the SUNFISH trial.

Patients with previous traumatic brain injury experienced significant improvement in motor functioning after implantation of mesenchymal stromal/stem cells, according to interim data from the STEMTRA phase 2 trial published in Neurology.